15.18
Uniqure N V Borsa (QURE) Ultime notizie
Liquidity Mapping Around (QURE) Price Events - Stock Traders Daily
uniQure Investors Sue Company Over Huntington’s Disease Drug Study Claims - TipRanks
QURE Shareholder Alert: uniQure N.V. Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm - PR Newswire
UNIQURE N.V. (QURE) Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action - marketscreener.com
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Holzer & Holzer, LLC Reminds Investors of April 13, 2026 - GlobeNewswire
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock DeclineInvestors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - ACCESS Newswire
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit - PR Newswire
Barclays Maintains uniQure (QURE) Rating, Lowers Price Target | QURE Stock News - GuruFocus
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 13, 2026 in uniQure Lawsuit – QURE - GlobeNewswire
uniQure (NASDAQ:QURE) Shares Down 4.9% After Analyst Downgrade - MarketBeat
Bronstein, Gewirtz & Grossman LLC Urges uniQure N.V. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
Barclays Maintains uniQure (QURE) Rating, Lowers Price Target | - GuruFocus
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Portnoy Law Firm Announces Class Action on Behalf of uniQure N.V. Investors - GlobeNewswire
QURE DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026 - Sahm
ROSEN, SKILLED INVESTOR COUNSEL, Encourages uniQure N.V. Investors to Secure Counsel Before ... - Bluefield Daily Telegraph
ROSEN, SKILLED INVESTOR COUNSEL, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
uniQure N.V. (QURE) Class Action Lawsuit: Investors Face April 13, 2026, Deadline - The Globe and Mail
UniQure surges following departure of key FDA official - MSN
Market Review: What are the analyst revisions for JPMPRPCIs uniQure NV stock a good investment in YEARDividend Hike & Growth Focused Entry Point Reports - baoquankhu1.vn
Investment Recap: Can uniQure NV continue delivering strong returnsMarket Activity Summary & Reliable Momentum Entry Alerts - baoquankhu1.vn
NASDAQ: QURE: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE) - The Globe and Mail
QURE stock crashes 32% in a week: Here's what you should know - MSN
QURE DEADLINE NOTICE: uniQure N.V. Investors Encouraged to Contact Kirby McInerney LLP By April 13, 2026 - ACCESS Newswire
uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V.QURE - Morningstar
uniQure Faces Investor Lawsuit Reminder - Intellectia AI
uniQure N.V. stock surges on positive Phase 1/ 2 data for AMT-130 in Huntington's disease - AD HOC NEWS
QURE SHAREHOLDER NOTICE: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of "Distorted" Data - PR Newswire
Energy Moves: Does uniQure NV have strong fundamentals2026 Volume Leaders & Reliable Price Breakout Signals - baoquankhu1.vn
uniQure N.V. (QURE) Securities Fraud Class Action Lawsuit - GlobeNewswire
QURE INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026 - TMX Newsfile
uniQure N.V. $QURE Shares Sold by JPMorgan Chase & Co. - MarketBeat
uniQure N.V. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your Rights - Benzinga
QURE ALERT: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of “Distorted” Data - GlobeNewswire Inc.
Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline – Company AnnouncementFT.com - Financial Times
uniQure N.V. Stockholders Should Contact Robbins LLP for Information About Leading the QURE Class Action - pharmiweb.com
UNIQURE CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Encourages uniQure N.V. ... - Bluefield Daily Telegraph
UNIQURE CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
uniQure (NASDAQ:QURE) Shares Up 5%Still a Buy? - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming DeadlinesQURE - PR Newswire
QURE DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026 - ChartMill
UNIQURE N.V. (QURE) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds uniQure N.V. Investors of ... - Bluefield Daily Telegraph
UNIQURE N.V. (QURE) SHAREHOLDER ALERT Bernstein Liebhard - GlobeNewswire
uniQure Shareholder Alert: ClaimsFiler Reminds Investors - GlobeNewswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 13, 2026 in uniQure LawsuitQURE - PR Newswire
Uniqure NV (QURE) - MSN
QURE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that uniQure N.V. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
QURE ALERT: Hagens Berman Updates uniQure (QURE) Investigation F - GuruFocus
QURE ALERT: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of "Distorted" Data – Company AnnouncementFT.com - Financial Times
A Huntington’s researcher on the UniQure-FDA fray - statnews.com
UniQure shares plunge 45% after FDA setback on Huntington’s gene therapy - MSN
UniQure NV (NASDAQ:QURE) Q4 2025 earnings call transcript - MSN
Why did QURE stock almost halve pre-market today? - MSN
QURE ALERT: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of "Distorted" Data - Sahm
QURE Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in uniQure N.V. Securities Lawsuit -- The Gross Law Firm - Lelezard
uniQure N.V. (QURE) Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP; April 13, 2026, Lead Plaintiff Deadline - The Globe and Mail
QURE ALERT: FDA Reportedly Accuses uniQure of Pushing - GlobeNewswire
QURE SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026 – Company AnnouncementFT.com - Financial Times
FinancialContentINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming Deadlines – QURE - FinancialContent
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages uniQure N.V. Investors to Secure Counsel Before ... - Bluefield Daily Telegraph
Holzer & Holzer, LLC Reminds Investors of April 13, 2026 Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Kyndryl Holdings, Inc. (KD) and uniQure N.V. (QURE) - The Daily Tribune News
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):